MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, SGMO has $59,965K in assets. $78,920K in debts. $27,586K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
69.85%
Quick Ratio
69.85%
Cash Ratio
51.92%
Debt to Asset Ratio
131.61%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Property and equipment, net
    • Refundable research income tax c...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Long-term portion of lease liabi...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
27,586 20,948 29,616 38,344
Restricted cash
--912 -
Accounts receivable
873 371 523 372
Refundable research income tax credits
5,491 10,142 4,602 4,604
Prepaid expenses and other current assets
3,164 4,369 8,423 6,573
Total current assets
37,114 35,830 44,076 49,893
Restricted cash
-0 0 1,500
Property and equipment, net
10,317 11,042 14,794 15,733
Operating lease right-of-use assets
2,905 3,064 14,428 15,061
Refundable research income tax credits, non-current
8,759 8,938 14,474 14,481
Other non-current assets
870 871 871 890
Total assets
59,965 59,745 88,643 97,558
Accounts payable
19,307 14,437 15,556 10,740
Accrued compensation and employee benefits
18,341 17,721 17,145 15,425
Other accrued liabilities
15,084 9,409 9,868 13,938
Deferred revenues
402 899 7,556 7,556
Total current liabilities
53,134 42,466 50,125 47,659
Deferred revenues, non-current
5,874 5,874 5,874 5,874
Long-term portion of lease liabilities
19,332 25,093 25,424 23,461
Other non-current liabilities
580 580 977 962
Total liabilities
78,920 74,013 82,400 77,956
Preferred stock
0 -0 0
Common stock
4,143 3,507 3,220 2,728
Additional paid-in capital
1,637,659 1,610,938 1,594,298 1,573,233
Accumulated deficit
-1,658,244 -1,627,249 -1,589,830 -1,554,900
Accumulated other comprehensive loss
-2,513 -1,464 -1,445 -1,459
Total stockholders deficit
-18,955 -14,268 6,243 19,602
Total liabilities and stockholders deficit
59,965 59,745 88,643 97,558
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$27,586K Refundable research incometax credits$5,491K Prepaid expenses andother current assets$3,164K Accounts receivable$873K Total current assets$37,114K Property and equipment,net$10,317K Refundable research incometax credits,...$8,759K Operating leaseright-of-use assets$2,905K Other non-currentassets$870K Total assets$59,965K Accumulated deficit-$1,658,244K Accumulated othercomprehensive loss-$2,513K Total liabilities andstockholders deficit$59,965K Total stockholdersdeficit-$18,955K Additional paid-in capital$1,637,659K Common stock$4,143K Total liabilities$78,920K Total currentliabilities$53,134K Long-term portion of leaseliabilities$19,332K Deferred revenues,non-current$5,874K Other non-currentliabilities$580K Accounts payable$19,307K Accrued compensationand employee...$18,341K Other accruedliabilities$15,084K Deferred revenues$402K

SANGAMO THERAPEUTICS, INC (SGMO)

SANGAMO THERAPEUTICS, INC (SGMO)